Major Depressive Disorder
📧 Sign up to get email alerts when something new happens for Major Depressive Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-06-27Clinical Trial Update: Chatbot for Depression, Anxiety, and Eating Disorders [NA]
A Dartmouth-Hitchcock Medical Center trial evaluating a chatbot for depression, anxiety, and eating disorders has completed.
-
CLINICAL_TRIALS research · 2025-06-27Clinical Trial Update: A Megastudy of Single-Session Interventions for Depression [NA]
A completed clinical trial investigating single-session interventions for major depressive disorder.
-
CLINICAL_TRIALS research · 2025-06-27Clinical Trial Update: ESAN III - Energy Sensing in Depression [NA]
The ESAN III trial from the Medical University of Graz is investigating energy sensing in depression, with obesity and gut microbiota modula…
-
CLINICAL_TRIALS research · 2025-06-27Clinical Trial Update: EEG-based Neurofeedback to Improve Emotion Regulation in Major Depressive Disorder: A Randomized Clinical Trial [NA]
Researchers are evaluating EEG-based neurofeedback to improve emotion regulation in individuals with major depressive disorder, including th…
-
CLINICAL_TRIALS research · 2025-06-27Clinical Trial Update: Internet Based Psychological Support [NA]
Dartmouth-Hitchcock Medical Center is conducting an internet-based psychological support trial evaluating depression and stress. The study i…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-06-26Clinical Trial Update: Molecular Signatures of TMS Response in Treatment-Resistant Depression [NA]
This clinical trial study investigates molecular signatures associated with response to transcranial magnetic stimulation in treatment-resis…
-
CLINICAL_TRIALS research · 2025-06-26Clinical Trial Update: Effects of Online Mindfulness Therapy on Pain and Stress in Adults With Chronic Migraine and Adverse Childhood Experiences [NA]
A clinical trial evaluating whether online mindfulness therapy reduces pain and stress in adults with chronic migraine and a history of adve…
-
CLINICAL_TRIALS trial_result · 2025-06-25Clinical Trial Update: A Prenatal Bonding Intervention for Pregnant Women With Depression [NA]
This clinical trial update reports the completion of a prenatal bonding intervention study for pregnant women with depression, with results …
-
CLINICAL_TRIALS research · 2025-06-25Clinical Trial Update: Supporting Patients Starting New Medicines: Evaluating the myCare Start Service in Switzerland [NA]
A clinical trial update from the University of Geneva evaluating the myCare Start Service in Switzerland to support patients starting new me…
-
CLINICAL_TRIALS withdrawal · 2025-06-25Clinical Trial Update: A Study of Participants With Moderate or Severe Major Depressive Disorder (MDD) Requiring Urgent Symptom Control in a Psychiatric Emergency
A clinical trial studying participants with moderate to severe major depressive disorder in a psychiatric emergency setting has been withdra…
-
CLINICAL_TRIALS research · 2025-06-25Clinical Trial Update: The Mental Health Experiences of Sexual and Gender Minorities Living With Cancer and Their Care Partners
A completed clinical trial from University of Alabama at Birmingham examining the mental health experiences of sexual and gender minorities …
-
CLINICAL_TRIALS research · 2025-06-25Clinical Trial Update: Intersession Processes in Psychotherapeutic Treatments Using an Ecological Momentary Assessment Approach (ISA-Bell) [NA]
A clinical trial investigating intersession processes in psychotherapeutic treatments for depression using an ecological momentary assessmen…
-
FDA label_change · 2025-06-24FDA Approved: RALDESY TM — Supplemental Application (Validus Pharmaceuticals LLC)
FDA approved a supplemental application for RALDESY TM (trazodone hydrochloride oral) from Validus Pharmaceuticals LLC, indicating a supplem…
-
FDA approval · 2025-06-24FDA Approved: TRAZODONE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for trazodone hydrochloride by Teva Pharmaceuticals USA, Inc., authorizing changes to the produc…
-
FDA approval · 2025-06-24FDA Approved: TRAZODONE HYDROCHLORIDE — Supplemental Application (Aurolife Pharma LLC)
FDA approved a supplemental application for trazodone hydrochloride by Aurolife Pharma LLC, indicating a regulatory action on this generic p…
-
FDA approval · 2025-06-24FDA Approved: AMITRIPTYLINE HYDROCHLORIDE — Supplemental Application (Centaur Pharmaceuticals Private Limited)
FDA approved a supplemental application for Amitriptyline Hydrochloride from Centaur Pharmaceuticals Private Limited to continue marketing t…
-
FDA approval · 2025-06-24FDA Approved: AMITRIPTYLINE HYDROCHLORIDE — Supplemental Application (Advagen Pharma Ltd)
The FDA approved a supplemental application for amitriptyline hydrochloride by Advagen Pharma Ltd, indicating an approved change to an alrea…
-
FDA approval · 2025-06-24FDA Approved: NORPRAMIN — Supplemental Application (Validus Pharmaceuticals LLC)
The FDA approves a supplemental application for Norpramin (desipramine hydrochloride) submitted by Validus Pharmaceuticals LLC.
-
FDA approval · 2025-06-24FDA Approved: IMIPRAMINE PAMOATE — Supplemental Application (Hikma Pharmaceuticals USA Inc)
FDA approved a supplemental application for Imipramine Pamoate by Hikma Pharmaceuticals USA Inc, enabling a generic imipramine pamoate produ…
-
FDA approval · 2025-06-24FDA Approved: TRAZODONE HYDROCHLORIDE — Supplemental Application (Oxford Pharmaceuticals, LLC)
FDA approved Oxford Pharmaceuticals' supplemental application for trazodone hydrochloride (generic antidepressant) under ANDA 072193.
-
FDA approval · 2025-06-24FDA Approved: IMIPRAMINE HYDROCHLORIDE — Supplemental Application (Strides Pharma Science Limited)
The FDA approved a supplemental application for imipramine hydrochloride from Strides Pharma Science Limited, enabling continued market avai…
-
FDA approval · 2025-06-24FDA Approved: TRAZODONE HYDROCHLORIDE — Supplemental Application (Rising Pharma Holdings, Inc.)
The FDA approved a supplemental application for trazodone hydrochloride from Rising Pharma Holdings, Inc., allowing the generic product to b…
-
FDA approval · 2025-06-24FDA Approved: IMIPRAMINE HYDROCHLORIDE — Supplemental Application (Oxford Pharmaceuticals, LLC)
FDA approved a supplemental application for imipramine hydrochloride (generic) from Oxford Pharmaceuticals, LLC. The action updates the labe…
-
FDA approval · 2025-06-24FDA Approved: BUPROPION HYDROCHLORIDE XL — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' supplemental application for Bupropion hydrochloride extended-release (XL), enabling the generic XL prod…
-
FDA approval · 2025-06-24FDA Approved: PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for a generic Perphenazine and Amitriptyline Hydrochloride product by Mylan Pharmaceuticals.